Preclinical News and Research

RSS
Discovery may lead to new treatment for neurodevelopmental, neurodegenerative disorders

Discovery may lead to new treatment for neurodevelopmental, neurodegenerative disorders

Researchers issue statement regarding use of unproven stem cell therapies

Researchers issue statement regarding use of unproven stem cell therapies

Regeneron Pharmaceuticals expands ophthalmology portfolio

Regeneron Pharmaceuticals expands ophthalmology portfolio

Preclinical data of Emergent BioSolutions' ES414 in mCRPC presented at PEGS 2013

Preclinical data of Emergent BioSolutions' ES414 in mCRPC presented at PEGS 2013

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

Everolimus reverses trastuzumab resistance in early HER-2 positive breast cancer

Everolimus reverses trastuzumab resistance in early HER-2 positive breast cancer

Study shows efficacy of PEGylated liposomal doxorubicin in intracranial model of breast cancer

Study shows efficacy of PEGylated liposomal doxorubicin in intracranial model of breast cancer

Scientists pursue new therapies as H7N9 flu spreads in China

Scientists pursue new therapies as H7N9 flu spreads in China

Targeted therapy prevents rare neurodevelopmental disorder seizures

Targeted therapy prevents rare neurodevelopmental disorder seizures

BioLineRx starts enrollment in Phase I/II trial of BL-8020 for treatment of HCV

BioLineRx starts enrollment in Phase I/II trial of BL-8020 for treatment of HCV

Opsona raises €33M in oversubscribed financing round

Opsona raises €33M in oversubscribed financing round

Transgene announces pre-clinical data of TG1050 for treatment of chronic hepatitis B infection

Transgene announces pre-clinical data of TG1050 for treatment of chronic hepatitis B infection

Shin Poong to develop, market Almac Discovery's ALM201 in South Korea

Shin Poong to develop, market Almac Discovery's ALM201 in South Korea

MorphoSys initiates Phase 2 clinical trial of MOR208 in B-cell acute lymphoblastic leukemia patients

MorphoSys initiates Phase 2 clinical trial of MOR208 in B-cell acute lymphoblastic leukemia patients

Derma Sciences initiates patient screening in DSC127 pivotal program for treatment of diabetic foot ulcers

Derma Sciences initiates patient screening in DSC127 pivotal program for treatment of diabetic foot ulcers

Calcipotriol drug offers a potential treatment option for fibrotic diseases

Calcipotriol drug offers a potential treatment option for fibrotic diseases

Multidrug-resistant tuberculosis (MDR-TB): an interview with Dr. Jennifer Cohn, Médecins Sans Frontières

Multidrug-resistant tuberculosis (MDR-TB): an interview with Dr. Jennifer Cohn, Médecins Sans Frontières

Mechanism of tumor suppressor p53 inactivation described

Mechanism of tumor suppressor p53 inactivation described

Perosphere, Daiichi Sankyo sign clinical trial agreement

Perosphere, Daiichi Sankyo sign clinical trial agreement

University of Guelph researchers develop carbohydrate-based vaccine against gut bug

University of Guelph researchers develop carbohydrate-based vaccine against gut bug

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.